The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcomes of stereotactic body radiotherapy in patients with clinical stage I non-small cell lung cancer who are fit to undergo surgery.
S. Senan
Consultant or Advisory Role - Varian Medical Systems
Honoraria - Varian Medical Systems
Research Funding - Varian Medical Systems
N. E. Verstegen
No relevant relationships to disclose
C. J. Haasbeek
No relevant relationships to disclose
B. J. Slotman
Consultant or Advisory Role - Varian Medical Systems
Honoraria - Varian Medical Systems
Research Funding - Varian Medical Systems
F. J. Lagerwaard
Honoraria - Varian Medical Systems